EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Chimeric Approach to Identify Molecular Determinants of Nicotinic Acetylcholine Receptors

Pooja Sapkota iD, Seyedeh Melika Akaberi iD, Biwash Ghimire iD, Kavita Sharma iD

International Journal of Molecular Sciences · 2026

DOI: 10.3390/ijms27021091 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Pooja Sapkota und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical and Pharmaceutical Sciences, College of Pharmacy, Idaho State University, Pocatello, ID 83209, USA. Hauptthemen laut MEDLINE: Receptors, Nicotinic, Recombinant Fusion Proteins. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 139 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nicotinic acetylcholine receptors (nAChRs) are membrane-bound proteins that mediate fast synaptic transmission throughout the nervous system. A functional nAChR subtype is formed by the combination of multiple subunits arranged as homomeric or heteromeric pentamers, each with a distinct pharmacological profile. Disruption of their neurotransmission contributes to various neuropathologies, emphasizing the need for detailed knowledge of receptor structure, function, subunit composition, dynamics, and potential ligand-binding sites. However, their structural complexity as integral membrane proteins has hindered expression in mammalian cell lines and proven even more challenging to crystallize, limiting insights into ligand interactions. Understanding the molecular determinants governing nAChRs function is essential for the rational design of selective therapeutics targeting neurological disorders. The emergence of a chimeric receptor approach has dramatically improved the ability to study these important proteins and opened new avenues for high-throughput screening in drug discovery efforts. This review explains how the design of chimera constructs using soluble homologs, such as AChBP, provides researchers with an immense opportunity to investigate receptor structure–function relationships and subtype-specific properties, thereby facilitating the development of more effective treatments.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, NicotinicRecombinant Fusion ProteinsHumansAnimalsProtein EngineeringBinding SitesModels, MolecularLigands

Stichwörter der Autor:innen

AlphaFoldacetylcholineacetylcholine binding proteinchimeracomputational modelingexpressionligand-gated ion channelsnicotinic receptorprotein engineeringrecombinant

Substanzen

Receptors, NicotinicRecombinant Fusion ProteinsLigands

Autor:innen und Institutionen

  • Department of Biomedical and Pharmaceutical Sciences, College of Pharmacy, Idaho State University, Pocatello, ID 83209, USA.

ORCID-Profile: Pooja Sapkota, Seyedeh Melika Akaberi, Biwash Ghimire, Kavita Sharma

Förderung

  • Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health

Zitieren

APA

Sapkota, P., Akaberi, S. M., Ghimire, B., & Sharma, K. (2026). Chimeric Approach to Identify Molecular Determinants of Nicotinic Acetylcholine Receptors. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27021091

Vancouver

Sapkota P, Akaberi SM, Ghimire B, Sharma K. Chimeric Approach to Identify Molecular Determinants of Nicotinic Acetylcholine Receptors. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27021091

BibTeX
@article{Sapkota2026,
  author = {Sapkota, Pooja and Akaberi, Seyedeh Melika and Ghimire, Biwash and Sharma, Kavita},
  title = {Chimeric Approach to Identify Molecular Determinants of Nicotinic Acetylcholine Receptors},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  doi = {10.3390/ijms27021091}
}
Kostenlos starten →